Third Quarter Earnings – A Perfect Messaging Opportunity, but Make it Quick.

earnings reportsWith earnings season right around the corner, many companies are putting final thoughts into their third quarter earnings materials and investors are taking out their 2020 checklists.  Earnings provides a perfect opportunity to highlight your recent accomplishments and to set up the fourth quarter and […]

By |2020-11-09T13:51:32-04:00October 8th, 2020|Biotech Investor Relations|Comments Off on Third Quarter Earnings – A Perfect Messaging Opportunity, but Make it Quick.

An Overview of COVID-19 and the Emerging Potential Treatment Landscape

Introduction

The 2019 Novel Coronavirus Disease (COVID-19) epidemic has roiled equity markets as recent headlines highlight disease spread outside of the initial epicenter in Wuhan, China. We reviewed the scientific / medical literature to provide an evidence-based summary of what is known about this outbreak, how it compares to others in recent memory and potential therapies […]

By |2020-03-05T17:42:49-04:00March 5th, 2020|Biotech Investor Relations|Comments Off on An Overview of COVID-19 and the Emerging Potential Treatment Landscape

Guidelines for IR Communications

As we look towards a new year and a fresh start, we are also thinking of how to start the year right with messaging.  Here are a few tips to keep in mind and practice when communicating with Wall Street:

Be forthright. Build […]

By |2019-12-19T15:43:27-04:00December 18th, 2019|Biotech Investor Relations|Comments Off on Guidelines for IR Communications
Go to Top